SUMMARY Tumour populations from two B cell neoplasms were investigated for their capacity to synthesise immunoglobulin in vitro. Neoplastic cells from a patient with chronic lymphocytic leukaemia and an IgG A paraproteinaemia co-expressed surface IgG A and IgM A and synthesised both IgG A and IgM A in short-term culture. In the second patient with non-Hodgkin's lymphoma,
serve as the prime antigen receptor, and it has been suggested that all immunoglobulin secreting clones arise from precursor cells bearing this isotype. [2] [3] [4] [5] [6] Thus, while clonal stability is preserved by maintaining the expression of one set of variable region genes during differentiation, adjunctive functional properties of immunoglobulin may be altered by a switch in the phenotypic expression of the heavy chain constant region genes. Such a switch from IgM to IgG synthesis has been well documented in vitro, and cells simultaneously expressing both classes have been described.7-'0 Many B-cell neoplasms appear to represent malignant clones frozen at a particular stage in B-cell differentiation." 12 The capacity of such neoplastic populations to synthesise immunoglobulin in vitro and their associative patterns of immunoglobulin expression have been related to that of normal morphological counterparts for both murine and human tumours. [13] [14] [15] [16] In this report we describe a case of chronic lymphocytic leukaemia (CLL) and a case of non-Hodgkin's lymphoma where the patterns of immunoglobulin expression and synthesis appeared to reflect a stage in normal B-cell Received for publication 20 The biosynthetic labelling techniques and the subsequent characterisation and quantification of labelled immunoglobulin have been described in detail elsewhere.16 Briefly, cells at 5 x 106 per ml were incubated in leucine-free medium containing 3H-leucine at 25 ,[Ci/ml for 18 hours at 370C. Cells were separated from the supernatants by centrifugation (150 g, 15 min) and lysed with phosphatebuffered saline (PBS) containing detergent NP40 and proteolytic inhibitors. Both the cell lysates and supernatants were spun at 35 000 g to remove cell debris and dialysed exhaustively against PBS. The radioactivity incorporated in all macromolecules was determined by precipitation with 10% trichloroacetic acid (TCA). Labelled immunoglobulin was precipitated using a sandwich technique with sheep antiserum specific for human immunoglobulin as the first antibody and rabbit antiserum with activity to sheep immunoglobulin as the second antibody. Normal sheep serum was used as the first antibody in control precipitations. These immunoglobulin precipitates were washed three times with cold PBS before counting or preparation for gel analysis. Reduced and alkylated immunoglobulin precipitates were analysed on 9*5 cm long 7 5% SDS-polyacrylamide gel electrophoresis with radioactive myeloma immunoglobulin markers. The labelled immunoglobulin light chain class was assessed by precipitation with K-or A-specific antiserum. These antisera were prepared from sheep immunised with pooled K-or A-Bence Jones protein and absorbed on Sepharose 4B (Pharmacia, Sweden) coupled to either K-or A-Bence Jones protein to remove crossreactivity. The specificity of these antisera has been described. 21 Antiserum specific for heavy chains in the immunoprecipitation test was not available at the time of this study.
Results
Final preparations were found to contain greater than 94% lymphoid cells, the remaining cells being either monocytes or granulocytes. In both preparations, strong staining for surface immunoglobulin (SIg) was observed on a majority of cells ( 
